Publicacións (89) Publicacións nas que participase algún/ha investigador/a

2024

  1. A Cross-Sectional Study to Assess the Knowledge of Pharmacy Students About Drug Pollution in Spain

    American Journal of Pharmaceutical Education, Vol. 88, Núm. 9

  2. A disturbed metabolite-GPCR axis is associated with microbial dysbiosis in IBD patients: Potential role of GPR109A in macrophages

    Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1870, Núm. 8

  3. A miRNA-based epigenetic molecular clock for biological skin-age prediction

    Archives of dermatological research, Vol. 316, Núm. 6, pp. 326

  4. A mild increase in nutrient signaling to mTORC1 in mice leads to parenchymal damage, myeloid inflammation and shortened lifespan

    Nature Aging, Vol. 4, Núm. 8, pp. 1102-1120

  5. Aberrant TIMP-1 production in tumor-associated fibroblasts drives the selective benefits of nintedanib in lung adenocarcinoma

    Cancer Science, Vol. 115, Núm. 5, pp. 1505-1519

  6. Alpha-1 antitrypsin deficiency

    Medicina Clinica, Vol. 162, Núm. 7, pp. 336-342

  7. Author Correction: Brain areas lipidomics in female transgenic mouse model of Alzheimer's disease (Scientific Reports, (2024), 14, 1, (870), 10.1038/s41598-024-51463-3)

    Scientific Reports

  8. Being fit in the COVID-19 era and future epidemics prevention: Importance of cardiopulmonary exercise test in fitness evaluation

    Progress in Cardiovascular Diseases, Vol. 83, pp. 84-91

  9. Benefits of rilpivirine for liver stiffness in HIV/HCV-coinfected patients

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 42, Núm. 2, pp. 74-79

  10. Beyond Weight Loss: Evaluating Cardiovascular Advantages of GLP-1 Receptor Agonists

    American Journal of Cardiovascular Drugs

  11. Brain areas lipidomics in female transgenic mouse model of Alzheimer's disease

    Scientific Reports, Vol. 14, Núm. 1

  12. COVID-19’s Consequences on the Cardiovascular System: Immediate, Intermediate, and Long-Term Complications

    Elsevier, pp. 1-274

  13. Cardiovascular benefits of SGLT2 inhibitors and GLP-1 receptor agonists through effects on mitochondrial function and oxidative stress

    Free Radical Biology and Medicine, Vol. 213, pp. 19-35

  14. Cardiovascular comorbidities and COVID-19 outcomes

    Covid-19's Consequences on the Cardiovascular System: Immediate, Intermediate, and Long-Term Complications (Elsevier), pp. 19-26

  15. Circadian alignment of food intake and glycaemic control by time-restricted eating: A systematic review and meta-analysis

    Reviews in Endocrine and Metabolic Disorders, Vol. 25, Núm. 2, pp. 325-337

  16. Circulating miR-28-5p is overexpressed in patients with sarcopenia despite long-term remission of Cushing’s syndrome: a pilot study

    Frontiers in Endocrinology, Vol. 15

  17. Conclusions and future perspectives

    Covid-19's Consequences on the Cardiovascular System: Immediate, Intermediate, and Long-Term Complications (Elsevier), pp. 255-259

  18. Correction to: Differential effectiveness of tyrosine kinase inhibitors in 2D/3D culture according to cell differentiation, p53 status and mitochondrial respiration in liver cancer cells (Cell Death & Disease, (2020), 11, 5, (339), 10.1038/s41419-020-2558-1)

    Cell Death and Disease

  19. Covid-19 and platelets: an enigmatic relationship

    Covid-19's Consequences on the Cardiovascular System: Immediate, Intermediate, and Long-Term Complications (Elsevier), pp. 129-134

  20. Deciphering fibroblast-induced drug resistance in non-small cell lung carcinoma through patient-derived organoids in agarose microwells

    Lab on a Chip